Esperion Therapeutics Inc. (NASDAQ: ESPR) completed its acquisition of Corstasis Therapeutics Inc., gaining rights to Enbumyst, a nasal spray loop ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE